Home › Funds › Paradigm Biocapital Advisors LP › TNGX

Paradigm Biocapital Advisors LP position in TNGX

TANGO THERAPEUTICS INC · Health Care

Paradigm Biocapital Advisors LP reported holding 6,961,546 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$173.7M, representing 3.45% of its reported portfolio and ranking #11 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed TNGX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)6.96M sh
Reported value held$173.69M
Portfolio Weight3.45%
First reportedQ3 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's TNGX position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in TNGX in Q3 2025 at 3,086,184 shares (US$25.9M). The position peaked in Q2 2026 at 6,357,523 shares, worth US$198.7M. Across 4 filings, Paradigm Biocapital Advisors LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,961,546 shares valued at US$173.7M — an increase of 604,023 shares quarter over quarter.. Notable position changes include a 59% increase in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.09M $25.92M New
Q1 2026 4.01M $83.88M New
Q2 2026 6.36M $198.74M Add
Q3 2026 6.96M $173.69M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held TNGX?

Paradigm Biocapital Advisors LP has disclosed TNGX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.

What is Paradigm Biocapital Advisors LP's current position in TNGX?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 6.96M shares of TNGX (TANGO THERAPEUTICS INC), valued at $173.69M, representing 3.45% of its reported portfolio and ranking #11.

Has Paradigm Biocapital Advisors LP been buying or selling TNGX?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP increased its position in TNGX. The position peaked in Q2 2026 at 6.36M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.